FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885280442> ?p ?o ?g. }

• W2885280442 endingPage "134" @default.
• W2885280442 startingPage "126" @default.
• W2885280442 abstract "Aspirin use probably protects against some malignancies but its effects on lethal prostate cancer (PC) are unclear.To investigate the association between regular aspirin use and lethal PC.Participants were aged 40-75 yr at baseline in 1986 and have been followed with biennial questionnaires. The risk analysis includes 49 409 men. The survival analysis includes 5980 PC patients without metastatic disease at diagnosis.We used Cox proportional hazards regression to examine the association between current, past, or never regular aspirin use (≥2 d/wk) in relation to lethal (metastatic or fatal) PC. We also examined years of use among current users and years since stopping among past users. In the risk analysis, aspirin was updated throughout follow-up. In the survival analysis, aspirin use after diagnosis was assessed.Some 29% of participants used aspirin regularly at baseline, which increased to 60% by 2010. In the risk analysis, 804 men were diagnosed with lethal PC. Current regular aspirin was associated with a lower risk of lethal prostate cancer (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.66-0.96) compared to never users. In the survival analysis, 451 of the men diagnosed with nonmetastatic PC later developed lethal disease. Current postdiagnostic aspirin was associated with a lower risk of lethal PC (HR 0.80, 95% CI 0.64-1.00) and overall mortality (HR 0.79, 95% CI 0.69-0.90). When restricted to highly screened men, the risk analysis associations were stronger and survival analysis associations remained statistically significant. Reverse causation and residual confounding remain concerns, as demonstrated by the attenuated results in sensitivity analyses.Regular aspirin use was associated with a lower risk of lethal PC. Postdiagnostic use was associated with better survival after diagnosis.We found that it may be advisable for prostate cancer patients to take aspirin to improve their survival for both prostate cancer mortality and other mortality outcomes." @default.
• W2885280442 created "2018-08-22" @default.
• W2885280442 creator A5017446229 @default.
• W2885280442 creator A5026112274 @default.
• W2885280442 creator A5029038256 @default.
• W2885280442 creator A5038373228 @default.
• W2885280442 creator A5049753330 @default.
• W2885280442 creator A5067413533 @default.
• W2885280442 creator A5080001095 @default.
• W2885280442 creator A5086101616 @default.
• W2885280442 creator A5087427252 @default.
• W2885280442 date "2019-03-01" @default.
• W2885280442 modified "2023-10-16" @default.
• W2885280442 title "Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study" @default.
• W2885280442 cites W1508398762 @default.
• W2885280442 cites W1550830253 @default.
• W2885280442 cites W1968519475 @default.
• W2885280442 cites W1968968729 @default.
• W2885280442 cites W1986726610 @default.
• W2885280442 cites W1989224896 @default.
• W2885280442 cites W1996765015 @default.
• W2885280442 cites W1998042325 @default.
• W2885280442 cites W2011106612 @default.
• W2885280442 cites W2028415685 @default.
• W2885280442 cites W2035739677 @default.
• W2885280442 cites W2041765569 @default.
• W2885280442 cites W2047076469 @default.
• W2885280442 cites W2089330652 @default.
• W2885280442 cites W2092660031 @default.
• W2885280442 cites W2106869018 @default.
• W2885280442 cites W2128271389 @default.
• W2885280442 cites W2148124028 @default.
• W2885280442 cites W2151036184 @default.
• W2885280442 cites W2154282264 @default.
• W2885280442 cites W2157201048 @default.
• W2885280442 cites W2158402121 @default.
• W2885280442 cites W2587228972 @default.
• W2885280442 cites W2599856343 @default.
• W2885280442 cites W2607809698 @default.
• W2885280442 cites W2614601052 @default.
• W2885280442 cites W4245466284 @default.
• W2885280442 cites W4247081510 @default.
• W2885280442 doi "https://doi.org/10.1016/j.euo.2018.07.002" @default.
• W2885280442 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31017087" @default.
• W2885280442 hasPublicationYear "2019" @default.
• W2885280442 type Work @default.
• W2885280442 sameAs 2885280442 @default.
• W2885280442 citedByCount "11" @default.
• W2885280442 countsByYear W28852804422020 @default.
• W2885280442 countsByYear W28852804422021 @default.
• W2885280442 countsByYear W28852804422022 @default.
• W2885280442 countsByYear W28852804422023 @default.
• W2885280442 crossrefType "journal-article" @default.
• W2885280442 hasAuthorship W2885280442A5017446229 @default.
• W2885280442 hasAuthorship W2885280442A5026112274 @default.
• W2885280442 hasAuthorship W2885280442A5029038256 @default.
• W2885280442 hasAuthorship W2885280442A5038373228 @default.
• W2885280442 hasAuthorship W2885280442A5049753330 @default.
• W2885280442 hasAuthorship W2885280442A5067413533 @default.
• W2885280442 hasAuthorship W2885280442A5080001095 @default.
• W2885280442 hasAuthorship W2885280442A5086101616 @default.
• W2885280442 hasAuthorship W2885280442A5087427252 @default.
• W2885280442 hasConcept C121608353 @default.
• W2885280442 hasConcept C126322002 @default.
• W2885280442 hasConcept C141071460 @default.
• W2885280442 hasConcept C207103383 @default.
• W2885280442 hasConcept C2777628954 @default.
• W2885280442 hasConcept C2780192828 @default.
• W2885280442 hasConcept C44249647 @default.
• W2885280442 hasConcept C50382708 @default.
• W2885280442 hasConcept C71924100 @default.
• W2885280442 hasConceptScore W2885280442C121608353 @default.
• W2885280442 hasConceptScore W2885280442C126322002 @default.
• W2885280442 hasConceptScore W2885280442C141071460 @default.
• W2885280442 hasConceptScore W2885280442C207103383 @default.
• W2885280442 hasConceptScore W2885280442C2777628954 @default.
• W2885280442 hasConceptScore W2885280442C2780192828 @default.
• W2885280442 hasConceptScore W2885280442C44249647 @default.
• W2885280442 hasConceptScore W2885280442C50382708 @default.
• W2885280442 hasConceptScore W2885280442C71924100 @default.
• W2885280442 hasIssue "2" @default.
• W2885280442 hasLocation W28852804421 @default.
• W2885280442 hasLocation W28852804422 @default.
• W2885280442 hasOpenAccess W2885280442 @default.
• W2885280442 hasPrimaryLocation W28852804421 @default.
• W2885280442 hasRelatedWork W1727188710 @default.
• W2885280442 hasRelatedWork W1988456684 @default.
• W2885280442 hasRelatedWork W2036310476 @default.
• W2885280442 hasRelatedWork W2088206352 @default.
• W2885280442 hasRelatedWork W2119154902 @default.
• W2885280442 hasRelatedWork W2133235702 @default.
• W2885280442 hasRelatedWork W2135028155 @default.
• W2885280442 hasRelatedWork W2203903734 @default.
• W2885280442 hasRelatedWork W2904476754 @default.
• W2885280442 hasRelatedWork W2917746345 @default.
• W2885280442 hasVolume "2" @default.
• W2885280442 isParatext "false" @default.
• W2885280442 isRetracted "false" @default.

• next